Cargando…

Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection

BACKGROUND: Human adenovirus (HAdV) infections remain a significant cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Efficient antiviral T-cell responses are necessary to clear infection, which is hampered by delayed immune reconstitution and medical immunosuppr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tischer, Sabine, Geyeregger, René, Kwoczek, Julian, Heim, Albert, Figueiredo, Constanca, Blasczyk, Rainer, Maecker-Kolhoff, Britta, Eiz-Vesper, Britta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055684/
https://www.ncbi.nlm.nih.gov/pubmed/27717382
http://dx.doi.org/10.1186/s12967-016-1042-2
_version_ 1782458794797694976
author Tischer, Sabine
Geyeregger, René
Kwoczek, Julian
Heim, Albert
Figueiredo, Constanca
Blasczyk, Rainer
Maecker-Kolhoff, Britta
Eiz-Vesper, Britta
author_facet Tischer, Sabine
Geyeregger, René
Kwoczek, Julian
Heim, Albert
Figueiredo, Constanca
Blasczyk, Rainer
Maecker-Kolhoff, Britta
Eiz-Vesper, Britta
author_sort Tischer, Sabine
collection PubMed
description BACKGROUND: Human adenovirus (HAdV) infections remain a significant cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Efficient antiviral T-cell responses are necessary to clear infection, which is hampered by delayed immune reconstitution and medical immunosuppression after HSCT. Protective immunity may be conferred by adoptive transfer of HAdV-specific T cells. For identification of patients at risk and monitoring of treatment responses diligent assessment of anti-HAdV cellular immune responses is crucial. The HAdV-derived protein hexon has been recognized as a major immunodominant target across HAdV species. We aimed at identifying further targets of protective anti-HAdV immune response and characterizing immunogenic epitopes. METHODS: Nineteen candidate nonamers from hexon and penton proteins were identified by epitope binding prediction. Peptides were synthesized and tested for in vivo immunogenicity by screening peripheral blood mononuclear cells from healthy volunteers (n = 64) and HAdV-infected stem cell recipients (n = 26) for memory T cells recognizing the candidate epitopes in the context of most common HLA alleles. RESULTS: Functional CD8(+) T cells recognizing seven epitopes were identified, among them four penton-derived and two hexon-derived peptides. The HLA-A*01-restricted penton-derived peptide STDVASLNY (A01Penton(STDV)) and HLA-A*02-restricted hexon-derived peptide TLLYVLFEV (A02Hexon(TLLY)) were recognized by more than half of the persons carrying the respective HLA-type. CONCLUSIONS: Thus, the HAdV-derived penton protein is a novel major target of the anti-HAdV immune response. Identification of new immunodominant epitopes will facilitate and broaden immune assessment strategies to identify patients suitable for T-cell transfer. Knowledge of additional target structures may increase T-cell recovery in manufacturing processes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-1042-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5055684
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50556842016-10-19 Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection Tischer, Sabine Geyeregger, René Kwoczek, Julian Heim, Albert Figueiredo, Constanca Blasczyk, Rainer Maecker-Kolhoff, Britta Eiz-Vesper, Britta J Transl Med Research BACKGROUND: Human adenovirus (HAdV) infections remain a significant cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Efficient antiviral T-cell responses are necessary to clear infection, which is hampered by delayed immune reconstitution and medical immunosuppression after HSCT. Protective immunity may be conferred by adoptive transfer of HAdV-specific T cells. For identification of patients at risk and monitoring of treatment responses diligent assessment of anti-HAdV cellular immune responses is crucial. The HAdV-derived protein hexon has been recognized as a major immunodominant target across HAdV species. We aimed at identifying further targets of protective anti-HAdV immune response and characterizing immunogenic epitopes. METHODS: Nineteen candidate nonamers from hexon and penton proteins were identified by epitope binding prediction. Peptides were synthesized and tested for in vivo immunogenicity by screening peripheral blood mononuclear cells from healthy volunteers (n = 64) and HAdV-infected stem cell recipients (n = 26) for memory T cells recognizing the candidate epitopes in the context of most common HLA alleles. RESULTS: Functional CD8(+) T cells recognizing seven epitopes were identified, among them four penton-derived and two hexon-derived peptides. The HLA-A*01-restricted penton-derived peptide STDVASLNY (A01Penton(STDV)) and HLA-A*02-restricted hexon-derived peptide TLLYVLFEV (A02Hexon(TLLY)) were recognized by more than half of the persons carrying the respective HLA-type. CONCLUSIONS: Thus, the HAdV-derived penton protein is a novel major target of the anti-HAdV immune response. Identification of new immunodominant epitopes will facilitate and broaden immune assessment strategies to identify patients suitable for T-cell transfer. Knowledge of additional target structures may increase T-cell recovery in manufacturing processes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-1042-2) contains supplementary material, which is available to authorized users. BioMed Central 2016-10-07 /pmc/articles/PMC5055684/ /pubmed/27717382 http://dx.doi.org/10.1186/s12967-016-1042-2 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Tischer, Sabine
Geyeregger, René
Kwoczek, Julian
Heim, Albert
Figueiredo, Constanca
Blasczyk, Rainer
Maecker-Kolhoff, Britta
Eiz-Vesper, Britta
Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection
title Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection
title_full Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection
title_fullStr Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection
title_full_unstemmed Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection
title_short Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection
title_sort discovery of immunodominant t-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055684/
https://www.ncbi.nlm.nih.gov/pubmed/27717382
http://dx.doi.org/10.1186/s12967-016-1042-2
work_keys_str_mv AT tischersabine discoveryofimmunodominanttcellepitopesrevealspentonproteinasasecondimmunodominanttargetinhumanadenovirusinfection
AT geyereggerrene discoveryofimmunodominanttcellepitopesrevealspentonproteinasasecondimmunodominanttargetinhumanadenovirusinfection
AT kwoczekjulian discoveryofimmunodominanttcellepitopesrevealspentonproteinasasecondimmunodominanttargetinhumanadenovirusinfection
AT heimalbert discoveryofimmunodominanttcellepitopesrevealspentonproteinasasecondimmunodominanttargetinhumanadenovirusinfection
AT figueiredoconstanca discoveryofimmunodominanttcellepitopesrevealspentonproteinasasecondimmunodominanttargetinhumanadenovirusinfection
AT blasczykrainer discoveryofimmunodominanttcellepitopesrevealspentonproteinasasecondimmunodominanttargetinhumanadenovirusinfection
AT maeckerkolhoffbritta discoveryofimmunodominanttcellepitopesrevealspentonproteinasasecondimmunodominanttargetinhumanadenovirusinfection
AT eizvesperbritta discoveryofimmunodominanttcellepitopesrevealspentonproteinasasecondimmunodominanttargetinhumanadenovirusinfection